A hospital safety programme is tied to a 65% drop in deadly MRSA bloodstream infections

A federally funded quality improvement program built with infection-prevention specialists at the Johns Hopkins Armstrong Institute for Patient Safety and Quality cut hospital-onset MRSA bloodstream infections by 65% at the intensive care and general units that ran it. The Agency for Healthcare Research and Quality’s Safety Program for MRSA Prevention ran for 18 months in 106 intensive care units and 87 non-ICUs at 94 hospitals across the United States, with researchers comparing infection rates during that period against the 12 months before the program began. Lisa Maragakis, the study’s senior author and a professor of medicine and epidemiology at the Johns Hopkins University School of Medicine, said multidrug-resistant infections such as MRSA get treated as inevitable by many people, when infection-prevention specialists have long known otherwise.

Methicillin-resistant Staphylococcus aureus is a strain of staph bacteria resistant to the antibiotics normally used against it, and hospitalized patients face elevated exposure because central venous catheters and other invasive devices cross the skin’s natural barrier and open a direct route into the bloodstream. Maragakis described pulling existing evidence into daily practice as a genuinely complex task, one that depends on making sure every frontline team member has the knowledge, skills and tools to apply it, and on building hospital systems and workflows that guarantee those steps happen for every patient, every single time.

The Program Ran 18 Months Across 106 ICUs and 87 Other Units

Researchers compared infection rates recorded during the 18-month implementation period against the 12 months immediately before the program launched. Across the 193 participating units at 94 hospitals nationwide, the rate of hospital-onset MRSA bloodstream infections was 65% lower during the implementation period, the finding that anchors the study. The Armstrong Institute team worked alongside collaborators from NORC at the University of Chicago and the Agency for Healthcare Research and Quality itself, a three-way arrangement Maragakis said supplied the coordination and infrastructure a project of that scale needed to reach hospitals nationwide.

Chlorhexidine Bathing and Nasal Decolonization Anchored the Intervention

Participating units received a structured bundle of education and implementation resources covering hand hygiene, environmental cleaning, device-associated infection prevention, chlorhexidine bathing and nasal decolonization, and organizers deliberately built the rollout to reach environmental services personnel alongside doctors and nurses rather than treating infection control as a physician-only responsibility. That broader reach showed up directly in the behavior the program was designed to change.

The share of ICUs reporting nasal MRSA decolonization for every patient climbed from 35% to 61%, and the share of non-ICUs doing the same rose from 13% to 35%. Monitoring of environmental cleaning increased from 50% to 75% among ICUs and from 52% to 76% among non-ICUs, the kind of routine, unglamorous compliance tracking the 65% drop in bloodstream infections ultimately rested on.

Environmental services personnel rarely appear in infection-prevention training built around doctors and nurses, yet the surfaces they clean are exactly where MRSA persists between patients. Treating their inclusion as a structural design choice, rather than an afterthought added on top of clinical training, is part of what the Armstrong Institute team points to when explaining why compliance moved as much as it did across both intensive care and general units.

Three More Infection Rates Fell Alongside the 65% Figure

The 65% reduction was not the only number to move. Researchers also recorded a 39% reduction in MRSA-positive clinical cultures collected later in a hospital stay, a 37% reduction in bloodstream infections from all causes, and a 31% reduction in central line-associated bloodstream infections specifically, according to the findings published in JAMA Network Open. Those overlapping declines matter because a program built around one organism’s transmission pathways — hand contact, contaminated skin, invasive lines — tends to interrupt other infections riding the same pathways, and not just the one it was named for.

Central line-associated bloodstream infections in particular are a metric hospitals already report to federal quality programs, so a 31% drop there carries consequences for a hospital’s public quality scores that sit apart from the MRSA-specific finding. Bloodstream infections caused by resistant organisms such as MRSA also tend to extend hospital stays and raise the odds of a harder recovery compared with infections caused by antibiotic-susceptible bacteria, which is part of why the research team frames prevention, not treatment, as the higher-leverage target.

The Toolkit Behind the Drop Is Now Public

The resulting AHRQ MRSA Prevention Toolkit is publicly available and lets hospitals select components based on an individual unit’s needs rather than adopting the entire bundle at once. Eight other Johns Hopkins researchers contributed to the study alongside Maragakis, including Clare Rock, Valeria Fabre, Sara Cosgrove, Kathleen Speck, Samuel Kim, Kerri Huber, Cheryl Conners and Sandra Swoboda, work funded and guided by the Agency for Healthcare Research and Quality under contract HHSP233201500020I/75P00120F37009.

Maragakis disclosed receiving AHRQ grants during the study while also serving as president of the Society for Healthcare Epidemiology of America, and co-author Sara Cosgrove disclosed AHRQ grant support alongside separate, unrelated consulting fees from Danaher, Philips and the Duke Clinical Research Institute — the kind of routine disclosure that accompanies a federally funded study of this scale.

“It really was a large collaborative project,” Maragakis said. “Each researcher brought something different to the table, and that was important to making a project of this scale possible.” The toolkit’s authors add that its strategies reach beyond MRSA specifically, since many of the same hand-hygiene and environmental-cleaning practices behind the 65% drop also interrupt the transmission routes other healthcare-associated infections depend on.

More from Morning Overview

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.